Best Herbal Extracts

Reference Substances

Vinblastine

Vinblastine, a powerful chemotherapeutic agent derived from the Madagascar periwinkle plant (Catharanthus roseus), marks a breakthrough in the fight against cancer. This alkaloid has been pivotal in the treatment of a wide range of cancers, including Hodgkin’s lymphoma, non-Hodgkin’s lymphoma, breast cancer, and testicular cancer, among others. By inhibiting cell division, Vinblastine disrupts the growth of cancer cells, offering hope and improved outcomes to patients worldwide. As part of our commitment to advancing cancer care, we provide high-quality Vinblastine to healthcare professionals and researchers seeking to make a difference in the lives of those affected by cancer.

SKU HE5005 Category

Vinblastine Overview

Vinblastine, a powerful chemotherapeutic agent derived from the Madagascar periwinkle plant (Catharanthus roseus), marks a breakthrough in the fight against cancer. This alkaloid has been pivotal in the treatment of a wide range of cancers, including Hodgkin’s lymphoma, non-Hodgkin’s lymphoma, breast cancer, and testicular cancer, among others. By inhibiting cell division, Vinblastine disrupts the growth of cancer cells, offering hope and improved outcomes to patients worldwide. As part of our commitment to advancing cancer care, we provide high-quality Vinblastine to healthcare professionals and researchers seeking to make a difference in the lives of those affected by cancer.

Vinblastine Key Benefits

  • Potent Anticancer Activity: Vinblastine has proven efficacy in halting the proliferation of cancer cells, playing a crucial role in comprehensive cancer treatment regimens.
  • Versatile Application: Effective in treating various types of cancers, providing healthcare practitioners with a valuable tool in oncological care.
  • Enhanced Patient Outcomes: When used in combination with other chemotherapeutic agents, Vinblastine has been shown to improve survival rates and quality of life for cancer patients.
  • Research Supported: Continuously supported by clinical research, Vinblastine remains at the forefront of oncology, with studies exploring new therapeutic applications and combination therapies.

Vinblastine Product Details

  • Purity: Our Vinblastine is synthesized to the highest standards of purity, ensuring maximum therapeutic efficacy.
  • Source: Derived from Catharanthus roseus, with a focus on sustainable and ethical sourcing practices.
  • Formulation: Available in injectable form, to be administered by healthcare professionals according to specific therapeutic needs.
  • Packaging: Securely packaged to maintain stability and potency, our Vinblastine is prepared with the utmost care to ensure safety and effectiveness in clinical settings.

How to Use Vinblastine

Vinblastine is administered intravenously under the supervision of a healthcare professional, with dosages and treatment schedules tailored to the individual needs of each patient. Treatment involving Vinblastine must be guided by oncologists specialized in chemotherapy, ensuring the best possible outcomes for patients.

Why Choose Our Vinblastine?

  • Superior Quality and Efficacy: We are dedicated to providing healthcare professionals with Vinblastine of the highest quality, backed by rigorous quality control processes.
  • Commitment to Innovation: Our ongoing investment in research and development ensures that our Vinblastine formulations meet the latest standards of cancer care.
  • Expert Support: We offer comprehensive support to healthcare providers, including detailed product information and guidance on the optimal use of Vinblastine in treatment protocols.
  • Ethical Sourcing: Committed to ethical practices, we ensure that our Vinblastine is produced in a way that respects both the environment and the communities involved in its sourcing.

Details

CAS#

865-21-4

Purity

≥98%HPLC

Package

20mg;1g









    Reviews

    There are no reviews yet.

    Be the first to review “Vinblastine”

    Your email address will not be published. Required fields are marked *